75% of the target number participated in the first 12 days of volunteering

A large turnout of children volunteers to study the immune response to the “Sinopharma” vaccination

  • The participation of any child in the study takes place with the full consent of the parent.

    From the source

  • Provide maximum possible care to young volunteers.

    From the source

picture

The supplementary study of the immune response to the Sinopharm vaccine for children aged between three and 17 years witnessed a high turnout of children "young volunteers", to participate with the full consent of their parents, as the participation rate reached about 75% of the target number who volunteered in the study, in less than Two weeks, which reflects societal support for the state’s proactive step in confronting the (Covid-19) pandemic, providing protection for all members of society of all groups against infection, and the confidence of citizens and residents in the efficiency and strength of the health system in the state.

The UAE is the first country in the Middle East and North Africa to conduct a study on the effectiveness of the vaccine for this age group, as the study aims to monitor the immune response to the Sinopharm vaccine in 900 children of all nationalities, with the aim of vaccinating children in the near future, and the participation of each child in this study will be After the full consent of the parent, he will be subject to close monitoring and follow-up, as the study places the safety of the children participating in it at the top of its priority. Parents and children will be provided with full details of participation and will receive necessary support during every step of the process.

The study, approved by the Department of Health - Abu Dhabi, under the supervision of the Ministry of Health and Community Protection, and launched on the 10th of this June, witnessed wide participation, as the number of volunteers from children with the approval of their parents reached 674 children in the first 12 days of its announcement, and a group of children participating in the study confirmed The complementary study of the immune response to the Sinopharm vaccine in children in Abu Dhabi, their joy in participating and supporting the national vaccination campaign, and contributing to the efforts to combat the pandemic in the UAE to protect themselves and those around them from all evil.

While the families of the children welcomed the participation of their children, and expressed their support for the study, and their pride in their children for their contribution to protecting themselves and the efforts to protect members of society. The official spokesman for the health sector in the country, Dr. Farida Al Hosani, confirmed, during her presence with her volunteer child, that her daughter Mary was the one who convinced her to participate in the The study, not the other way around, noting that she has no doubts about the safety of vaccination, but her daughter is participating in the study to follow up on this matter, and prove it scientifically, stressing that her daughter Maryam is very excited to participate in the study.

The mother of two children participating in the study attributed the motive that encouraged her to agree to their participation in the study, to her desire for her children to live in safety and health, and to lead their lives normally. We must be keen to vaccinate them to protect them from any harm, and our elders brought their children to participate in the vaccination, which encouraged us to participate and reassured us of the safety of vaccination, because our leadership is our role model.”

For his part, the consultant in the medical wing of Sheikh Khalifa Medical City, Dr. Salah Al-Din Hussein, confirmed that talking about the desire to reach community immunity requires working to vaccinate the largest percentage of society, and the segment of children and adolescents in the Emirati society constitutes a large percentage, so the aim of the study is to obtain On a permit to give the vaccination to those under 16 years of age, stressing that the degree of safety of the vaccination is excellent for different ages.

The Associate Professor of Pediatrics and Infectious Diseases and Head of the Department of Pediatrics at the United Arab Emirates University, Dr. Ahmed Dimas Al-Suwaidi, indicated that for generations, children have received safe vaccines against multiple diseases and viruses, and the Sinopharm vaccine does not differ in its concept and method of action from these vaccines, pointing out that the state It is very close to the stage of eliminating the pandemic, with the availability of vaccines against (Covid-19), especially since the research conducted so far has shown that these vaccines are very effective and safe.

While teachers and officials in public and private schools, Khamis Abdullah, Muhammad Adel, Maryam Nasser, Shorouk Ahmed, Fatima Al Balushi, and Laila Salama, expect that if the results of the study are announced and the age of the two vaccinated from the Sinopharma vaccine goes down to three years before the beginning of the next academic year, the number of Immunized children have a noticeable increase, especially with the announcement of the Emirates Foundation for School Education, the return of the face-to-face education system in public schools, starting from the next school year 2021-2022, and the approval of the Emergency, Crisis and Disaster Management Committee in the Emirate of Abu Dhabi, to return to the face-to-face learning system in the Emirate of Abu Dhabi. Schools for all students for the next academic year.

For its part, the Department of Health - Abu Dhabi confirmed that the UAE plays an active role in the global efforts to combat (Covid-19), including the process of developing vaccines.

This study follows the successes achieved by the country in conducting clinical trials for a number of vaccines, which resulted in confirming their effectiveness in reducing infection rates and reducing symptoms with the participation of multiple nationalities.

This in turn led to the licensing of these vaccines, and their official registration, as they were used to vaccinate citizens and residents of the country.

As of May 2021, the UAE ranked first in the world in terms of vaccination rates against (Covid-19).

Super baby care

Dr. Nawal Al Kaabi, chair of the National Committee for the Clinical Management of Coronavirus, which is leading the study, said: “We focused on ensuring that the utmost care possible for our young volunteers throughout the process of conducting the Sinopharm Immune Response Study. We want children and their families to feel safe at every step of the process. And to be sure that we will be with them and support them throughout the study, and answer every question they may have at any time.”

She added: "Due to the increasing number of people who have received the vaccination in the UAE, we are seeking to ensure that our children are able to receive the vaccine safely as well, as the study comes at a time when the global mutation of the virus has led to an increase in the number of infections and an increase in the severity of its symptoms, including widespread infections. Among children, this includes transmission of the virus from children to others, especially people who have a high risk of infection and its complications,” stressing that vaccinating children will protect them and maintain the health of those around them, and will contribute to accelerating access to the group immunity necessary to limit the spread of the virus.

Pfizer for kids

The official spokesman for the health sector in the country, Dr. Farida Al-Hosani, confirmed that vaccinating children aged 12-15 years, with the Pfizer vaccine, is a stage of the national vaccination campaign, which began with the elderly and adults category, because coronavirus infections are more common among them, She stressed that "vaccinating children helps us in the recovery stage, and allows us to provide a safer environment during school times, next year, and this category has been identified based on scientific studies," and she said: "We have noticed an increasing demand from parents to vaccinate their children at this age." Since the announcement of the availability of the Pfizer-Biontech vaccine for children from 12 years of age.

And she confirmed the start of vaccinating this category after ascertaining the safety of the vaccine, "We are keen on our children, and we will not allow any vaccination to enter until we are sure of its safety and effectiveness."

Al Hosani called on children’s families to “take vaccination into consideration,” because it “helps the medical and educational sectors, and contributes to the completion of societal immunity.”

• 900 children of all nationalities targeted for study.

Follow our latest local and sports news and the latest political and economic developments via Google news